Primitive neuroectodermal tumor: Difference between revisions

Revision as of 17:55, 25 January 2016

Latest revision as of 16:41, 22 September 2024

(35 intermediate revisions by 16 users not shown)

Line 1:

{{Short description|Cancer of the developing nervous system}}

{{hatnote|Not to be confused with [[pancreatic neuroendocrine tumor]], which is also abbreviated as PNET.}}

{{Infobox medical condition (new)

{{Infobox_Disease |

| name Name = Primitive neuroectodermal tumor |

| image Image = PNET_Histopathology_HE_200x.jpg |

| caption Caption = Micrograph of an H&E stained section of a peripheral PNET.
|

| pronounce DiseasesDB = 31470 |

| field ICD10 = | Oncology

| synonyms ICD9 = = |PNET

| ICDO symptoms = {{ICDO|9473|3}} |

| OMIM complications = |

| onset MedlinePlus = | =

| duration =

eMedicineSubj = ped |

| types =

eMedicineTopic = 2589 |

| causes =

eMedicine_mult = {{eMedicine2|neuro|326}} |

| risks MeshID = D018242 |

| diagnosis =

| differential =

| prevention =

| treatment =

| medication =

| prognosis =

| frequency =

| deaths =

}}

'''Primitive neuroectodermal tumor''' (PNET) is a malignant (cancerous) [[neural crest]] tumor.<ref>{{DorlandsDict|eight/000112249|primitive neuroectodermal tumor}}</ref> It is a rare [[tumor]], usually occurring in children and young adults under 25 years of age. The overall 5 year survival rate is about 53%.<ref name=Smoll20111>{{Cite journal | last1 = Smoll | first1 = N. R. | title = Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs) | doi = 10.1002/cncr.26387 | journal = Cancer | volume = 118 | issue = 5 | pages = 1313–1322 | year = 2012 | pmid = 21837678| pmcs2cid = 8490276 | doi-access = free }}</ref>

It gets its name because the majority of the cells in the tumor are derived from [[neuroectoderm]], but have not developed and differentiated in the way a normal [[neuron]] would, and so the cells appear "primitive". PNET belongs to the [[Ewing family of tumors]].

==Genetics==

PNET belongs to the [[Ewing family of tumors]].

Using gene transfer of SV40 large T-antigen in neuronal precursor cells of rats, a brain tumor model was established. The PNETs were histologically indistinguishable from the human counterparts and have been used to identify new genes involved in human brain tumor carcinogenesis.<ref name="pmid8129041">{{cite journal |authorvauthors=Eibl RH, Kleihues P, Jat PS, Wiestler OD |title=A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen |journal=Am. J. Pathol. |volume=144 |issue=3 |pages=556–64 |date=March 1994 |pmid=8129041 |pmc=1887088 |doi= |url=}}</ref> The model was used to confirm p53 as one of the genes involved in human medulloblastomas, but since only about 10% of the human tumors showed mutations in that gene, the model can be used to identify the other binding partners of SV40 Large T- antigen, other than p53.<ref name="pmid1933879">{{cite journal |authorvauthors=Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P |title=p53 mutations in nonastrocytic human brain tumors |journal=Cancer Res. |volume=51 |issue=22 |pages=6202–5 |date=November 1991 |pmid=1933879 |doi= |url=http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=1933879}}</ref>{{additional citation needed|date=July 2021}}

==Classification==

It is classified into two types, based on ___location in the body: peripheral PNET and CNS PNET.

==Diagnosis==

===Peripheral PNET===

[[File:Peripheral PNET CD99 200x.jpg|thumb|CD99 staining of tissue from peripheral PNET]]

===Classification===

It is classified into two types, based on ___location in the body: peripheral PNET and CNS PNET.{{citation needed|date=June 2020}}

====Peripheral PNET====

The peripheral PNET (pPNET) is now thought to be virtually identical to [[Ewing's sarcoma|Ewing sarcoma]]:

"Current evidence indicates that both Ewing's sarcoma and PNET have a similar neural phenotype and, because they share an identical chromosome translocation, they should be viewed as the same tumor, differing only in their degree of neural differentiation. Tumors that demonstrate neural differentiation by light microscopy, immunohistochemistry, or electron microscopy have been traditionally labeled PNETs, and those that are undifferentiated by these analyses have been diagnosed as Ewing's sarcoma."<ref name="robbins">Kumar, Vinay; Fausto, Nelso; Abbas, Abul (2004) ''Robbins & Cotran Pathologic Basis of Disease'' (7th ed.). Saunders. Page 1301. {{ISBN |0-7216-0187-1}}.</ref>

====PNET of the CNS====

[[File:PNET.jpg|thumb|Supratentorial central PNET in a 5-year-old patient]]

{{main|Central nervous system primitive neuroectodermal tumor}}

PNET of the CNS generally refer to supratentorial PNETs.

* In the past [[medulloblastoma]]s were considered PNETs; however, they are genetically, transcriptionally and clinically distinct. As such, "infratentorial" PNETs are now referred to as medulloblastoma {{Citation needed|date=March 2013}}.

* In the past [[medulloblastoma]]s were considered PNETs; however, they are genetically, transcriptionally and clinically distinct. As such, "infratentorial" PNETs are now referred to as medulloblastoma {{Citation needed|date=March 2013}}.

* [[Pineoblastoma]]s are embryonal tumours originating in the [[pineal gland]] and are likely distinct from supratentorial PNETs.

==ModelTreatment==

Using gene transfer of SV40 large T-antigen in neuronal precursor cells of rats, a brain tumor model was established. The PNETs were histologically indistinguishable from the human counterparts and have been used to identify new genes involved in human brain tumor carcinogenesis.<ref name="pmid8129041">{{cite journal |author=Eibl RH, Kleihues P, Jat PS, Wiestler OD |title=A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen |journal=Am. J. Pathol. |volume=144 |issue=3 |pages=556–64 |date=March 1994 |pmid=8129041 |pmc=1887088 |doi= |url=}}</ref> The model was used to confirm p53 as one of the genes involved in human medulloblastomas, but since only about 10% of the human tumors showed mutations in that gene, the model can be used to identify the other binding partners of SV40 Large T- antigen, other than p53.<ref name="pmid1933879">{{cite journal |author=Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P |title=p53 mutations in nonastrocytic human brain tumors |journal=Cancer Res. |volume=51 |issue=22 |pages=6202–5 |date=November 1991 |pmid=1933879 |doi= |url=http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=1933879}}</ref>

The approach to management of a CNS PNET is first to obtain detailed imaging through MRI, as well as additional scans of the patient's body (X-ray, CT, PET, even bone marrow biopsies) to look for metastasis or other associated malignancies. The tumor will then need to be biopsied to confirm the diagnosis. After the diagnosis of a CNS PNET is confirmed, management includes neoadjuvant chemotherapy and radiation (to reduce tumor size burden), complete surgical resection with confirmed negative margins, and/or additional adjuvant post-surgical chemotherapy. CNS PNET is aggressive and must be managed as so. Palliative care services should also become involved in the patient's care team when the diagnosis is made.

<ref>Honrado, Carlo P, and Augustine L Moscatello. Primitive Neuroectodermal Tumors: Background, Epidemiology, Clinical Features, Medscape, 21 Jan. 2021, emedicine.medscape.com/article/855644-overview#a7.</ref>

==See also==

* [[Medulloblastoma]]

*[[Ewing family of tumors]]

* [[Ependymoma]]

PNET belongs to the* [[Ewing family of tumors]].

*[[medulloblastoma]]

==References==

{{reflist|2Reflist}}

{{Medical resources

| DiseasesDB = 31470

| ICD10 =

| ICD9 =

| ICDO = {{ICDO|9473|3}}

| OMIM =

| MedlinePlus =

| eMedicineSubj = ped |

| eMedicineTopic = 2589 |

| eMedicine_mult = {{eMedicine2|neuro|326}} |

| MeshID = D018242

}}

{{Nervous tissue tumors}}

{{Osseous and chondromatous tumors}}

{{Small blue round cell tumors}}

[[Category:PediatricsPediatric cancers]]

[[Category:Rare cancers]]

[[Category:Nervous system neoplasia]]

[[Category:Small -blue -round -cell tumortumors]]